Vitalograph has announced the acquisition of Massachusetts-based Morgan Scientific, strengthening its U.S. commercial footprint and enabling it to meet the growing global demand for its innovative solutions, particularly in advanced pulmonary function testing solutions.
Vitalograph is a leading global provider of respiratory diagnostic solutions and clinical drug trial services, based in Ennis Co Clare.
Speaking of the acquisition, Frank Keane, CEO of Vitalograph said: “We have a long and successful relationship with Morgan Scientific.
“This agreement is the natural progression for both companies as our combined expertise allows us to focus on delivering the best possible diagnostic solutions that can enable a better understanding of lung health.”
Morgan Scientific is an expert in customer-facing software for advanced PFT systems.
ComPAS2, the company’s flagship software powers Vitalograph’s range of advanced PFT solutions, the VitaloPFT Series.
Morgan Scientific is also a key distributor for Vitalograph’s pulmonary function testing solutions in the US.
Speaking of their collaboration to date, Mr …